| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2388 | 2004 |
| Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease R Pahwa, MA Stacy, SA Factor, KE Lyons, F Stocchi, BP Hersh, LW Elmer, ... Neurology 68 (14), 1108-1115, 2007 | 393 | 2007 |
| Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD RA Hauser, JP Hubble, DD Truong, Istradefylline US-001 Study Group Neurology 61 (3), 297-303, 2003 | 357 | 2003 |
| A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 344 | 2014 |
| Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism RR Matsumoto, WD Bowen, MA Tom, DD Truong, BR De Costa European journal of pharmacology 280 (3), 301-310, 1995 | 305 | 1995 |
| Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders M Hallett, A Albanese, D Dressler, KR Segal, DM Simpson, D Truong, ... Toxicon 67, 94-114, 2013 | 287 | 2013 |
| Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double‐blind, placebo‐controlled study D Truong, DD Duane, J Jankovic, C Singer, LC Seeberger, CL Comella, ... Movement disorders: official journal of the Movement Disorder Society 20 (7 …, 2005 | 277 | 2005 |
| The natural history of embouchure dystonia SJ Frucht, S Fahn, PE Greene, C O'Brien, M Gelb, DD Truong, J Welsh, ... Movement disorders 16 (5), 899-906, 2001 | 210 | 2001 |
| Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia D Truong, M Brodsky, M Lew, A Brashear, J Jankovic, E Molho, O Orlova, ... Parkinsonism & related disorders 16 (5), 316-323, 2010 | 201 | 2010 |
| Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphonia DD Truong, M Rontal, M Rolnick, AE Aronson, K Mistura The Laryngoscope 101 (6), 630-634, 1991 | 199 | 1991 |
| Management of non-motor symptoms in advanced Parkinson disease DD Truong, R Bhidayasiri, E Wolters Journal of the neurological sciences 266 (1-2), 216-228, 2008 | 188 | 2008 |
| ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson disease (EASE LID study): a randomized clinical trial R Pahwa, CM Tanner, RA Hauser, SH Isaacson, PA Nausieda, ... JAMA neurology 74 (8), 941-949, 2017 | 184 | 2017 |
| Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia CL Comella, J Jankovic, DD Truong, A Hanschmann, S Grafe, ... Journal of the neurological sciences 308 (1-2), 103-109, 2011 | 180 | 2011 |
| Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study) R Pahwa, CM Tanner, RA Hauser, K Sethi, S Isaacson, D Truong, ... Movement Disorders 30 (6), 788-795, 2015 | 165 | 2015 |
| Gonadal-and sex-chromosome-dependent sex differences in the circadian system DA Kuljis, DH Loh, D Truong, AM Vosko, ML Ong, R McClusky, AP Arnold, ... Endocrinology 154 (4), 1501-1512, 2013 | 164 | 2013 |
| Voluntary scheduled exercise alters diurnal rhythms of behaviour, physiology and gene expression in wild‐type and vasoactive intestinal peptide‐deficient mice AM Schroeder, D Truong, DH Loh, MC Jordan, KP Roos, CS Colwell The Journal of physiology 590 (23), 6213-6226, 2012 | 163 | 2012 |
| Botulinum toxin: clinical use DD Truong, WH Jost Parkinsonism & related disorders 12 (6), 331-355, 2006 | 157 | 2006 |
| Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia N Pankratz, L Byder, C Halter, A Rudolph, CW Shults, PM Conneally, ... Movement disorders: official journal of the Movement Disorder Society 21 (1 …, 2006 | 153 | 2006 |
| Levodopa-induced dyskinesia: clinical features, incidence, and risk factors TN Tran, TNN Vo, K Frei, DD Truong Journal of Neural Transmission 125, 1109-1117, 2018 | 150 | 2018 |
| Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial L Neurol Lancet Neurol 14 (8), 795-803, 2015 | 147 | 2015 |